
0:00
36:15
“I think this was such an important trial, certainly one that has changed my practice already.” Dr Barnes welcomes Dr Marco Proietti for a review and discussion of key studies presented at ESC 2025, including AMALFI, ALONE-AF, and HI-PRO. Which results were practice-changing, which were reassuring, and which are of uncertain value or highlight a need for new therapeutics?
Flere episoder fra "Thrombosis in conversation"



Gå ikke glip af nogen episoder af “Thrombosis in conversation” - abonnér på podcasten med gratisapp GetPodcast.








